Results

Pfizer Inc.

05/23/2022 | Press release | Distributed by Public on 05/23/2022 04:52

Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose